A report on HIV and blood supply was critical of the FDA in the way it had managed regulation of blood and blood products in the early 1980s, and for having relied too heavily on the pharmaceutical industry.
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Regulation of Commercial Factor Concentrates